Advisory Services Network’s MacroGenics MGNX Stock Holding History

Advisory Services Network’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-71	Closed	-$205	–	3662
2026 Q1	$205	Buy	+71	New	+$151	﹤0.01%	4559
2025 Q4	–	Sell	-71	Closed	-$119	–	3308
2025 Q3	$119	Buy	+71	New	+$115	﹤0.01%	4312
2020 Q4	–	Sell	-21	Closed	-$1K	–	3534
2020 Q3	$1K	Buy	+21	New	+$573	﹤0.01%	3345

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Advisory Services Network's MGNX Position: Q2 2026 in Review

Advisory Services Network sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 71 shares — an estimated $205 sold.

Advisory Services Network first reported a position in MGNX in Q3 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2020. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Advisory Services Network reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 71 MacroGenics shares in Q2 2026, an estimated $205.
Advisory Services Network first reported a position in MacroGenics in Q3 2020 and held it in 3 quarters.
Advisory Services Network's MacroGenics position peaked at $1K in Q3 2020.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.